(Q33451429)

English

The efficacy of arsenic trioxide for the treatment of relapsed and refractory multiple myeloma: a systematic review

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

title

The efficacy of arsenic trioxide for the treatment of relapsed and refractory multiple myeloma: a systematic review (English)

1 reference

stated in

Europe PubMed Central

26 July 2017

0 references

1 reference

1

Christoph Röllig

1 reference

stated in

Europe PubMed Central

26 July 2017

Thomas Illmer

2

1 reference

stated in

Europe PubMed Central

26 July 2017

22 May 2009

1 reference

stated in

Europe PubMed Central

26 July 2017

Cancer Treatment Reviews

1 reference

stated in

Europe PubMed Central

26 July 2017

35

1 reference

stated in

Europe PubMed Central

26 July 2017

5

1 reference

stated in

Europe PubMed Central

26 July 2017

425-430

1 reference

stated in

Europe PubMed Central

PubMed ID

19464807

retrieved

26 July 2017

Identifiers

DOI

10.1016/J.CTRV.2009.04.007

1 reference

stated in

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

PubMed ID

19464807

retrieved

26 July 2017

ResearchGate publication ID

26236420

0 references

(Q33451429)

The efficacy of arsenic trioxide for the treatment of relapsed and refractory multiple myeloma: a systematic review

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)